COMMUNIQUÉS West-GlobeNewswire
-
Ultragenyx Announces the Marketing Authorisation Application (MAA) for its Investigational Gene Therapy for MPS IIIA (Sanfilippo syndrome Type A) is Under Review with the UK Medicines and Healthcare Products Regulatory Agency (MHRA)
06/11/2026 -
Le KFSH de Riyad figure parmi les 5 % des meilleurs établissements de santé au monde pour le tourisme médical selon le classement 2027 de Newsweek
06/11/2026 -
Avance Clinical Brings 30 Years of Early-Phase and Therapeutic Leadership to European Biotechs at BIO-Europe 2026
06/11/2026 -
MHRA approves Pharming’s Joenja® (leniolisib) as first treatment specifically for children with APDS in the U.K.
06/11/2026 -
Orchestra BioMed Announces Pricing of Public Offering
06/11/2026 -
Global Health Congress 2026 Draws 625+ Leaders From 25 Countries to New York, Names Venture Forum Winners and Announces National and International Expansion
06/11/2026 -
BioAge Labs Reports Third Quarter 2026 Financial Results and Provides Business Updates
05/11/2026 -
Elutia Reports Third Quarter 2026 Results: As Plastic Surgeons Cite Infection Risk in Every Breast Research Session During National Meeting, NXT-41x Heads to FDA This Quarter, Fully Funded Through Launch
05/11/2026 -
CytomX Therapeutics Announces Q3 2026 Financial Results and Provides Business Update
05/11/2026 -
Nephros Announces Strong Third Quarter 2026 Financial Results
05/11/2026 -
TerrAscend Reports Third Quarter 2026 Financial Results
05/11/2026 -
Gyre Therapeutics Reports Third Quarter 2026 and Year-to-Date Financial Results with Business Updates
05/11/2026 -
Starling Oncology Reports Third Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance
05/11/2026 -
Aligos Therapeutics Presents Positive Data at The Liver Meeting® 2026
05/11/2026 -
Organogenesis Holdings Inc. Reports Third Quarter 2026 Financial Results
05/11/2026 -
Eton Pharmaceuticals Reports Third Quarter 2026 Financial Results
05/11/2026 -
Larimar Therapeutics Announces Three Poster Presentations for the Nomlabofusp Program at the Upcoming International Congress for Ataxia Research
05/11/2026 -
Aprea Therapeutics to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference
05/11/2026 -
MacroGenics to Participate in Upcoming Investor Conferences
05/11/2026
Pages